Clinical trials
Phase 3 trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5,867 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 23 |
| 2001 | 45 |
| 2002 | 58 |
| 2003 | 90 |
| 2004 | 110 |
| 2005 | 129 |
| 2006 | 183 |
| 2007 | 172 |
| 2008 | 210 |
| 2009 | 209 |
| 2010 | 209 |
| 2011 | 227 |
| 2012 | 243 |
| 2013 | 261 |
| 2014 | 238 |
| 2015 | 261 |
| 2016 | 233 |
| 2017 | 282 |
| 2018 | 294 |
| 2019 | 276 |
| 2020 | 304 |
| 2021 | 355 |
| 2022 | 307 |
| 2023 | 292 |
| 2024 | 300 |
| 2025 | 306 |
| 2026 | 186 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3,494 |
| Active, not recruiting | 770 |
| Terminated | 717 |
| Recruiting | 656 |
| Unknown status | 138 |
| Enrolling by invitation | 34 |
| Withdrawn | 29 |
| Not yet recruiting | 25 |
| Suspended | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 309 |
| Hoffmann-La Roche | 305 |
| AstraZeneca | 274 |
| Pfizer | 203 |
| Eli Lilly and Company | 202 |
| GlaxoSmithKline | 191 |
| Sanofi | 184 |
| Bristol-Myers Squibb | 152 |
| Merck Sharp & Dohme LLC | 133 |
| Janssen Research & Development, LLC | 129 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 222 |
| Breast Neoplasms | 201 |
| Diabetes Mellitus, Type 2 | 201 |
| Neoplasms | 118 |
| Multiple Myeloma | 97 |
| Neoplasm Metastasis | 96 |
| Diabetes Mellitus | 94 |
| Pulmonary Disease, Chronic Obstructive | 94 |
| Prostatic Neoplasms | 92 |
| Arthritis, Rheumatoid | 85 |
Trials
Showing 1 to 25 of 5,867. Each trial links to its page on Pharma Observatory.
5,767 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.